Emmanuel J Favaloro/LinkedIn
Jan 9, 2026, 07:19
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of a bleeding disorder “pseudo-hemophilia’ that was later to become known as von Willebrand disease.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the first one in queue – on type 2A VWD.
Enjoy!”
Read the full article here.
Article: Von Willebrand Disease Type 2A: An Update
Authors: Omid Seidizadeh , Luciano Baronciani , Pier Mannuccio Mannucci , Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?